Currently, there are 99.55M common shares owned by the public and among those 92.77M shares have been available to trade.
The company’s stock has a 5-day price change of 0.69% and 62.13% over the past three months. MBLY shares are trading -59.58% year to date (YTD), with the 12-month market performance down to -56.46% lower. It has a 12-month low price of $10.48 and touched a high of $44.48 over the same period. MBLY has an average intraday trading volume of 6.93 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 2.03%, 17.71%, and -19.65% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Mobileye Global Inc (NASDAQ: MBLY) shares accounts for 11.38% of the company’s 99.55M shares outstanding.
It has a market capitalization of $14.12B and a beta (3y monthly) value of 0.44. The earnings-per-share (ttm) stands at -$3.65. Price movements for the stock have been influenced by the stock’s volatility, which stands at 8.63% over the week and 6.43% over the month.
Earnings per share for the fiscal year are expected to decrease by -72.19%, and 79.28% over the next financial year. EPS should shrink at an annualized rate of -8.70% over the next five years, compared to 46.60% over the past 5-year period.
Loop Capital coverage for the Mobileye Global Inc (MBLY) stock in a research note released on November 12, 2024 offered a Buy rating with a price target of $20. TD Cowen was of a view on November 01, 2024 that the stock is Buy, while RBC Capital Mkts gave the stock Sector Perform rating on October 15, 2024, issuing a price target of $24- $11. Mizuho on their part issued Neutral rating on October 11, 2024.
